Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: A dose-response meta-analysis

American Journal of Epidemiology

Volumn 180, Issue 8, 2014, Pages 763-775

  Crippa, Alessio ^a   Discacciati, Andrea ^a   Larsson, Susanna C ^a   Wolk, Alicja ^a   Orsini, Nicola ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

All cause mortality; Cancer mortality; Cardiovascular disease mortality; Coffee; Dose response relationship; Metaanalysis; Prospective studies

Indexed keywords

CANCER; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COFFEE; DOSE-RESPONSE RELATIONSHIP; FOOD CONSUMPTION; FOOD INTAKE; INDIVIDUAL-BASED MODEL; META-ANALYSIS; MORTALITY RISK; RISK FACTOR;

ALL CAUSE MORTALITY; ARTICLE; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; COFFEE CONSUMPTION; CONFIDENCE INTERVAL; FOOD INTAKE; HUMAN; META ANALYSIS; MORTALITY; NEOPLASM; PROSPECTIVE STUDY; RISK REDUCTION; SENSITIVITY ANALYSIS; CARDIOVASCULAR DISEASES; COFFEE; DOSE RESPONSE; DRINKING BEHAVIOR; EPIDEMIOLOGY; FEMALE; MALE; NEOPLASMS; RISK FACTOR; SEX DIFFERENCE; SMOKING;

COFFEE;

ALCOHOL DRINKING; CARDIOVASCULAR DISEASES; COFFEE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; NEOPLASMS; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 84919349889     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwu194     Document Type: Article

References (57)

1. Noordzij M, Uiterwaal C S PM, Arends LR, et al. Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J Hypertens. 2005;23(5):921-928.
2. Hartley TR, Lovallo WR, Whitsett TL. Cardiovascular effects of caffeine in men and women. Am J Cardiol. 2004;93(8):1022-1026.
3. Jee SH, He J, Appel LJ, et al. Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol. 2001;153(4):353-362.
4. Rebello SA, van Dam RM. Coffee consumption and cardiovascular health: getting to the heart of the matter. Curr Cardiol Rep. 2013;15(10):403.
5. van Dam RM, Feskens E J M. Coffee consumption and risk of type 2 diabetes mellitus. Lancet. 2002;360(9344):1477-1478.
6. Kempf K, Herder C, Erlund I, et al. Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. Am J Clin Nutr. 2010;91(4):950-957.
7. Ding M, Bhupathiraju SN, Chen M, et al. Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a dose-response meta-analysis. Diabetes Care. 2014;37(2):569-586.
8. Ding M, Bhupathiraju SN, Satija A, et al. Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation. 2014;129(6):643-659.
9. Yu X, Bao Z, Zou J, et al. Coffee consumption and risk of cancers: a meta-analysis of cohort studies. BMC Cancer. 2011;11:96.
10. Malerba S, Turati F, Galeone C, et al. A meta-analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular diseases. Eur J Epidemiol. 2013;28(7):527-539.
11. Je Y, Giovannucci E. Coffee consumption and total mortality: a meta-analysis of twenty prospective cohort studies. Br J Nutr. 2014;111(7):1162-1173.
12. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283(15):2008-2012.
13. Hamling J, Lee P, Weitkunat R, et al. Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med. 2008;27(7):954-970.
14. Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized dose-response data. Stata J. 2006;6(1):40-57.
15. Orsini N, Li R, Wolk A, et al. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol. 2012;175(1):66-73.
16. Jackson D, White IR, Thompson SG. Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analyses. Stat Med. 2010;29(12):1282-1297.
17. Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med. 2010;29(9):1037-1057.
18. Higgins J P T, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558.
19. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634.
20. Crippa A. Dosresmeta: Performing Multivariate Dose-Response Meta-Analysis. Vienna, Austria: R Foundation for Statistical Computing; 2013. http://CRAN. R-project.org/package=dosresmeta. Accessed January 20, 2014.
21. Viechtbauer W. metafor: Meta-Analysis Package for R. Vienna, Austria: R Foundation for Statistical Computing; 2010. http://CRAN. R-project.org/package=metafor. Accessed January 20, 2014.
22. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2009. http://www. R-project.org. Accessed January 20, 2014.
23. Le Grady D, Dyer AR, Shekelle RB, et al. Coffee consumption and mortality in the ChicagoWestern Electric Company Study. Am J Epidemiol. 1987;126(5):803-812.
24. Rosengren A, Wilhelmsen L. Coffee, coronary heart disease and mortality in middle-aged Swedish men: findings from the Primary Prevention Study. J Intern Med. 1991;230(1):67-71.
25. Klatsky AL, Armstrong MA, Friedman GD. Coffee, tea, and mortality. Ann Epidemiol. 1993;3(4):375-381.
26. Woodward M, Tunstall-Pedoe H. Coffee and tea consumption in the Scottish Heart Health Study follow up: conflicting relations with coronary risk factors, coronary disease, and all cause mortality. J Epidemiol Community Health. 1999;53(8):481-487.
27. Kleemola P, Jousilahti P, Pietinen P, et al. Coffee consumption and the risk of coronary heart disease and death. Arch Intern Med. 2000;160(22):3393-3400.
28. Iwai N, Ohshiro H, Kurozawa Y, et al. Relationship between coffee and green tea consumption and all-cause mortality in a cohort of a rural Japanese population. J Epidemiol. 2002;12(3):191-198.
29. Jazbec A, Simicì D, Corovicì N, et al. Impact of coffee and other selected factors on general mortality and mortality due to cardiovascular disease in Croatia. J Health Popul Nutr. 2003;21(4):332-340.
30. Andersen LF, Jacobs DR Jr, Carlsen MH, et al. Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the IowaWomen's Health Study. Am J Clin Nutr. 2006;83(5):1039-1046.
31. Paganini-Hill A, Kawas CH, Corrada MM. Non-alcoholic beverage and caffeine consumption and mortality: the Leisure World Cohort Study. Prev Med. 2007;44(4):305-310.
32. Lopez-Garcia E, van Dam RM, Li TY, et al. The relationship of coffee consumption with mortality. Ann Intern Med. 2008;148(12):904-914.
33. Happonen P, Läärä E, Hiltunen L, et al. Coffee consumption and mortality in a 14-year follow-up of an elderly northern Finnish population. Br J Nutr. 2008;99(6):1354-1361.
34. Ahmed HN, Levitan EB, Wolk A, et al. Coffee consumption and risk of heart failure in men: an analysis from the Cohort of Swedish Men. Am Heart J. 2009;158(4):667-672.
35. de Koning Gans JM, Uiterwaal C S P M, van der Schouw YT, et al. Tea and coffee consumption and cardiovascular morbidity and mortality. Arterioscler Thromb Vasc Biol. 2010;30(8):1665-1671.
36. Sugiyama K, Kuriyama S, Akhter M, et al. Coffee consumption and mortality due to all causes, cardiovascular disease, and cancer in Japanese women. J Nutr. 2010;140(5):1007-1013.
37. Tamakoshi A, Lin Y, Kawado M, et al. Effect of coffee consumption on all-cause and total cancer mortality: findings from the JACC Study. Eur J Epidemiol. 2011;26(4):285-293.
38. Freedman ND, Park Y, Abnet CC, et al. Association of coffee drinking with total and cause-specific mortality. N Engl J Med. 2012;366(20):1891-1904.
39. Liu J, Sui X, Lavie CJ, et al. Association of coffee consumption with all-cause and cardiovascular disease mortality. Mayo Clin Proc. 2013;88(10):1066-1074.
40. Gardener H, Rundek T, Wright CB, et al. Coffee and tea consumption are inversely associated with mortality in a multiethnic urban population. J Nutr. 2013;143(8):1299-1308.
41. Hart C, Smith GD. Coffee consumption and coronary heart disease mortality in Scottish men: a 21 year follow up study. J Epidemiol Community Health. 1997;51(4):461-462.
42. Leurs LJ, Schouten LJ, Goldbohm RA, et al. Total fluid and specific beverage intake and mortality due to IHD and stroke in the Netherlands Cohort Study. Br J Nutr. 2010;104(8):1212-1221.
43. Mineharu Y, Koizumi A, Wada Y, et al. Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. J Epidemiol Community Health. 2011;65(3):230-240.
44. Heckman MA, Weil J, Gonzalez de Mejia E. Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. J Food Sci. 2010;75(3):R77-R87.
45. van Dam RM. Coffee consumption and coronary heart disease: paradoxical effects on biological risk factors versus disease incidence. Clin Chem. 2008;54(9):1418-1420.
46. Natella F, Scaccini C. Role of coffee in modulation of diabetes risk. Nutr Rev. 2012;70(4):207-217.
47. Lucas M, O'Reilly EJ, Pan A, et al. Coffee, caffeine, and risk of completed suicide: results from three prospective cohorts of American adults. World J Biol Psychiatry. 2014;15(5):377-386.
48. Hernán MA, Takkouche B, Caamaño-Isorna F, et al. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol. 2002;52(3):276-284.
49. Leitzmann MF, Willett WC, Rimm EB, et al. A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men. JAMA. 1999;281(22):2106-2112.
50. Lopez-Garcia E, van Dam RM, Qi L, et al. Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr. 2006;84(4):888-893.
51. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135-1143.
52. Roivainen M, Viik-Kajander M, Palosuo T, et al. Infections, inflammation, and the risk of coronary heart disease. Circulation. 2000;101(3):252-257.
53. Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology (Williston Park). 2002;16(2):217-226, 229.
54. Ferraroni M, Tavani A, Decarli A, et al. Reproducibility and validity of coffee and tea consumption in Italy. Eur J Clin Nutr. 2004;58(4):674-680.
55. Cornelis MC, El-Sohemy A, Kabagambe EK, et al. Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA. 2006;295(10):1135-1141.
56. Bagnardi V, Zambon A, Quatto P, et al. Flexible metaregression functions for modeling aggregate dose-response data, with an application to alcohol and mortality. Am J Epidemiol. 2004;159(11):1077-1086.
57. Bortner RW, et al. A short rating scale as a potential measure of pattern A behavior. J Chronic Dis. 1969;22(2):87-91.